Arcimoto, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Stock Information for DMK Pharmaceuticals Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About DMK Pharmaceuticals Corporation

Arcimoto to Present at the Sequire Investor Summit in Puerto Rico
DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth
Arcimoto Enters into Contract Manufacturing Agreement with MOBIUS.energy to Build Battery Packs for the Aviation Market
Arcimoto to Unveil New Tap Variation of the MUV at the Del Mar Wine + Food Festival, Sept. 9-10
Arcimoto Announces Second Quarter 2023 Financial Results
Arcimoto provides MATBOCK with Electrical Systems Architecture and Energy Storage Systems for Development of Electric and Hybrid Utility Vehicles
Arcimoto to Report Second Quarter 2023 Financial Results on August 24, 2023
Arcimoto, Inc. Announces $6.7 Million Series D Preferred Stock and Warrant Offering

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.